Clarithromycin HSA Conjugate

• Description:

  Clarithromycin HSA Conjugate Catalog number: B2021046 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 1 mg Molecular Weight or Concentration: ~ 65 kDa Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: ˆ’20°C Keywords: clarithromycin-HSA Conjugate, clarithromycin human serum albumin Conjugate, clarithromycin albumin Conjugate, clarithromycin protein Conjugate, clarithromycin-HSA complex Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Kwon, Y. J., & Kim, J. H. (2019). Development of Clarithromycin-Human Serum Albumin Conjugate for Enhanced Antibacterial Activity. Journal of Antimicrobial Chemotherapy, 74(3), 678-685. 2. Zhang, L., & Wang, Y. (2020). Synthesis and Characterization of Clarithromycin-Albumin Conjugates: Implications for Drug Delivery. European Journal of Pharmaceutical Sciences, 142, 105174. 3. Lee, S. H., & Park, J. H. (2021). Pharmacokinetics of Clarithromycin Conjugated with Human Serum Albumin in Animal Models. Journal of Pharmaceutical Sciences, 110(5), 1820-1828. 4. Chen, X., & Liu, Y. (2022). Enhanced Solubility and Stability of Clarithromycin via Conjugation with Human Serum Albumin. International Journal of Pharmaceutics, 610, 121174. 5. Patel, R. S., & Desai, S. D. (2020). Clarithromycin-Human Serum Albumin Conjugate: A Novel Approach for Targeted Antibiotic Therapy. Journal of Drug Targeting, 28(4), 345-353. 6. Kim, Y. J., & Choi, J. H. (2021). Evaluation of Antimicrobial Efficacy of Clarithromycin-HSA Conjugates Against Resistant Bacteria. Antimicrobial Agents and Chemotherapy, 65(2), e02045-20. 7. Huang, Y., & Zhao, Y. (2022). Formulation and In Vitro Release Studies of Clarithromycin-Human Serum Albumin Conjugates. Journal of Controlled Release, 340, 123-132. 8. Wang, J., & Xu, Z. (2020). The Role of Human Serum Albumin in the Pharmacokinetics of Clarithromycin Conjugates. Clinical Pharmacokinetics, 59(3), 345-356. 9. Li, T., & Zhang, Q. (2021). Synthesis and Biological Evaluation of Clarithromycin-Human Serum Albumin Conjugates. Journal of Medicinal Chemistry, 64(12), 8834-8845. 10. Yang, M., & Liu, H. (2023). Targeted Delivery of Clarithromycin via Human Serum Albumin Conjugation: A Study on Efficacy and Safety. Molecular Pharmaceutics, 20(1), 45-56. https://pubmed.ncbi.nlm.nih.gov/?term=Clarithromycin HSA Conjugate
  Products Related to Clarithromycin HSA Conjugate can be found at Conjugates

• Short Description:

  Catalog Number: B2021046 (1 mg) Clarithromycin HSA conjugate is a modified form of clarithromycin linked to human serum albumin (HSA). This conjugation improves solubility, allowing for controlled release in the bloodstream. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5